Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma

MLA

P, Lind, et al. “Technetium-99m-Tetrofosmin Whole-Body Scintigraphy in the Follow-up of Differentiated Thyroid Carcinoma.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 38, no. 3, Mar. 1997. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........4a90f6629796aefc47db3b648ef95c7a&authtype=sso&custid=ns315887.

APA

P, L., H J, G., W, L., E, K., P, M., & I, G. (1997). Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 38(3).

Chicago

P, Lind, Gallowitsch H J, Langsteger W, Kresnik E, Mikosch P, and Gomez I. 1997. “Technetium-99m-Tetrofosmin Whole-Body Scintigraphy in the Follow-up of Differentiated Thyroid Carcinoma.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 38 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........4a90f6629796aefc47db3b648ef95c7a&authtype=sso&custid=ns315887.